Soleno Therapeutics Publicizes Financing Dedication for up

Soleno Therapeutics Publicizes Financing Dedication for up

Funding from three main healthcare traders, with Vivo Capital becoming a member of current traders Nantahala Capital and Abingworth $10 million capital infusion at closing and $15 million upon constructive information to help NDA submission Extra $35 million capital upon FDA approval to allow commercialization REDWOOD CITY, Calif., Dec. 19, 2022 (GLOBE NEWSWIRE) — Soleno […]

Continue Reading